:

Mohamed H Mashali1, Gaser A Abdelmohsen1, Ahmed S Baamer1

  • 1From the Pediatric Cardiology Division (Mashali, Abdelmohsen, Baamer, Elhudairy, Alkhushi, Bahaidarah, Abdelsalam, Elakaby, Maghrabi, Azhar, Zaher, Al Ata, Dohain, Baamer), Department of Pediatrics, King Abdulaziz University, Jeddah, Saudi Arabia, From the Department of Cardiac Surgery (Al-Radi, Jamjoom, Shihata, Elmahrouk), King Faisal Specialist Hospital and Research Center, Jeddah, Saudi Arabia, From the Department of Pediatrics (Dohain), King Fahd Armed Forces Hospital, Jeddah, Saudi Arabia, From the Department of Cardiology (Abdelsalam), Banaha University, Banha, Egypt, From the Department of Pediatric (Elakaby) Al Azhar University, Cairo, Egypt and from the Division of Pediatric Cardiology (Mashali, Abdelmohsen, Dohain, Bekheet), Department of Pediatrics, Cairo University, Cairo, Egypt.

Saudi medical journal
|September 2, 2025
PubMed
まとめ

AVSD-TOFによる心房間隔膜欠陥の手術による早期生存は好ましいが,双心房間隔膜の修復は可能である. しかし複雑な症例では 再介入や残留病変により 個別的な計画と長期のフォローアップが必要です

関連する概念動画

Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
21
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
42
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
32
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
39
Mitral Stenosis IV: Nursing Management01:27

Mitral Stenosis IV: Nursing Management

A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
41
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
45